Search

Your search keyword '"Nishio, S."' showing total 1,952 results

Search Constraints

Start Over You searched for: Author "Nishio, S." Remove constraint Author: "Nishio, S."
1,952 results on '"Nishio, S."'

Search Results

1. Extraction of Research Objectives, Machine Learning Model Names, and Dataset Names from Academic Papers and Analysis of Their Interrelationships Using LLM and Network Analysis

2. Photonic quantum signatures of chaos and boson sampling

4. VP5-2023: Primary results from BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030), a randomised phase III trial of first-line atezolizumab (atezo) combined with a platinum doublet and bevacizumab (bev) for metastatic (stage IVB), persistent or recurrent cervical cancer (R/M CC)

6. Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes

13. Phase I Biomarker Analysis Results of MORAb-202 (Farletuzumab Ecteribulin) Effects on Vascular Remodeling and Immune Modulation in Patients With Ovarian Cancer

14. LBA31 Randomized phase III trial of maintenance chemotherapy with tegafur-uracil versus observation following concurrent chemoradiotherapy for locally advanced cervical cancer, GOTIC-002 LUFT trial

15. 534P A pilot study of neoadjuvant olaparib for patients with HRD-positive advanced ovarian cancer

16. Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability

19. Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus

22. Effects of Lecithinized SOD on Sequential Change in SOD Activity after Cerebral Contusion in Rats

25. 792P Analysis of postoperative adjuvant chemotherapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study

31. LBA41 Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva ± olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial

33. Effects of Lecithinized SOD on Contusion Injury in Rats

46. 807O Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)

47. 834P A phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear-cell carcinoma (KCOG-G1601 trial)

Catalog

Books, media, physical & digital resources